Sugi Predict

Sugi Predict / Compounds / SCHEMBL8350486

SCHEMBL8350486

SCHEMBL8350486

Cc1ccc(C(C)(C)CN)cc1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TAAR1 Q96RJ0 2/20 0.62
▸ TSHR P16473 1/20 0.52
▸ KIF11 P52732 6/20 0.42
▸ CYP1A2 P05177 1/20 0.41
▸ CYP2A6 P11509 1/20 0.41
▸ ACHE P22303 2/20 0.40
▸ TDP1 Q9NUW8 1/20 0.40
▸ NPC1 O15118 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ CA1 P00915 1/20 0.39
▸ CA2 P00918 1/20 0.39
▸ CA5A P35218 1/20 0.39
▸ CA9 Q16790 1/20 0.39
▸ SHBG P04278 1/20 0.37
▸ HTR2A P28223 1/20 0.36
▸ HTR2C P28335 1/20 0.36
▸ HTR2B P41595 1/20 0.36
▸ ESR1 P03372 1/20 0.35
▸ ESR2 Q92731 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL8508449 0.98 TAAR1 (0.60) TAAR1TSHRKIF11CYP1A2CYP2A6
SCHEMBL6562809 0.89 TAAR1 (0.75) TAAR1TSHRCYP1A2NPC1MAPT
Hydrochloric Acid SCHEMBL6563360 0.87 TAAR1 (0.71) TAAR1TSHRCYP1A2NPC1MAPT
SCHEMBL5877849 0.82 TAAR1 (0.65) TAAR1TSHRKIF11ACHENPC1
SCHEMBL10961852 0.82 TAAR1 (0.65) TAAR1KIF11NPC1MAPTRAB9A
SCHEMBL8354437 0.81 KIF11 (0.48) TAAR1TSHRKIF11CYP1A2CYP2A6
SCHEMBL10574062 0.80 TAAR1 (0.62) TAAR1TSHRKIF11CYP1A2ACHE
SCHEMBL12171 0.80 TAAR1 (0.62) TAAR1KIF11NPC1MAPTRAB9A
SCHEMBL144362 0.78 SHBG (0.61) TAAR1TSHRSHBGESR1ESR2
SCHEMBL793347 0.78 TAAR1 (0.60) TAAR1TSHRKIF11HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 87 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113993831-B Depolymerization of poly (carbonate) and separation of bisphenol A from depolymerized poly (carbonate) 高新特殊工程塑料全球技术有限公司 2024-07-02 — — CN disclosed
CN-114901743-B Flame retardant and thermally stable polyetherimides 高新特殊工程塑料全球技术有限公司 2024-05-10 — — CN disclosed
CN-117043269-A Thermoplastic composition and use thereof 高新特殊工程塑料全球技术有限公司 2023-11-10 — — CN disclosed
CN-116675953-A Crosslinkable Networks and Thermoset Polymers from Functionalized Polyetherimides 高新特殊工程塑料全球技术有限公司 2023-09-01 — — CN disclosed
CN-116601221-A Composition, method of making the same, and articles made therefrom 高新特殊工程塑料全球技术有限公司 2023-08-15 — — CN disclosed
CN-116583564-A Composition, method of making the same, and articles made therefrom 高新特殊工程塑料全球技术有限公司 2023-08-11 — — CN disclosed
CN-113166536-B High flow poly (phthalamide) compositions and articles made therefrom 高新特殊工程塑料全球技术有限公司 2023-07-14 — — CN disclosed
CN-113710725-B Crosslinkable networks from functionalized polyetherimides and thermoset polymers therefrom 高新特殊工程塑料全球技术有限公司 2023-07-07 — — CN disclosed
WO-2023083343-A1 POLYCYCLIC COMPOUNDS AND METHODS THEREOF HEPAITECH (BEIJING) BIOPHARMA TECHNOLOGY CO., LTD. (CN) 2023-05-19 — — WO disclosed
CN-113272360-B Thermoplastic composition, electrical wire, and article comprising electrical wire 高新特殊工程塑料全球技术有限公司 2023-03-03 — — CN disclosed
US-8461163-B2 Substituted N-(pyrazolo[1,5-a]pyrimidin-5-yl)amides as inhibitors of apoptosis signal-regulating kinase 1 TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2013-06-11 — — US disclosed
US-8361959-B2 Spiro-imidazolone derivatives as glucagon receptor antagonists MERCK SHARP & DOHME CORP. (US) 2013-01-29 — — US disclosed
US-20130012434-A1 NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE MERCK SHARP & DOHME CORP. 2013-01-10 — — US disclosed
EP-1609835-B1 CURING COMPOSITION AND METHOD FOR PREPARING SAME, LIGHT-SHIELDING PASTE, LIGHT-SHIELDING RESIN AND METHOD FOR PRODUCING SAME, PACKAGE FOR LIGHT-EMITTING DIODE, AND SEMICONDUCTOR DEVICE KANEKA CORP (JP) 2013-01-09 — — EP disclosed
US-20110306587-A1 UNSATURATED NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS AMGEN INC. 2011-12-15 — — US disclosed
US-20110077235-A1 APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-31 — — US disclosed
US-20110077235-A1 APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-03-31 — — US disclosed
US-7312214-B2 1, 1-disubstituted cycloalkyl derivatives as factor Xa inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2007-12-25 — — US disclosed
WO-2003099276-A1 1,1-DISUBSTITUTED CYCLOALKYL DERIVATIVES AS FACTOR XA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2003-12-04 — — WO disclosed
US-4734464-A IMPROVING SOLVENT RESISTANCE M&T CHEMICALS INC. (US) 1988-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110077235-A1 APOPTOSIS SIGNAL-REGULATING KINASE 1 INHIBITORS BAX, BCL2, BAD TAAR1 4395/4885TSHR 4184/4885KIF11 2307/4885
US-20130012434-A1 NOVEL SPIRO IMIDAZOLONES AS GLUCAGON RECEPTOR ANTAGONISTS, COMPOSITIONS, AND METHODS FOR THEIR USE GLP1R, GCGR, GIPR TAAR1 606/4885TSHR 44/4885KIF11 4328/4885
US-20110306587-A1 UNSATURATED NITROGEN HETEROCYCLIC COMPOUNDS USEFUL AS PDE10 INHIBITORS PDE10A, PDE2A, PDE3A TAAR1 1176/4885TSHR 2124/4885KIF11 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.